Papatheodoridis, G. V. Et Al. 2013. Risk and risk factors of hepatocellular carcinoma HCC in Caucasian chronic hepatitis B CHB patients with orwithout cirrhosis treated with entecavir ETV or tenofovir TDF. AASLD 2013 .

Papatheodoridis, G. V., Dalekos, G. N., YURTAYDIN, S. C., Goulis, I., Arends, P., Buti, M., ... Sypsa, V.(2013). Risk and risk factors of hepatocellular carcinoma HCC in Caucasian chronic hepatitis B CHB patients with orwithout cirrhosis treated with entecavir ETV or tenofovir TDF . AASLD 2013

Papatheodoridis, ONUR Et Al. "Risk and risk factors of hepatocellular carcinoma HCC in Caucasian chronic hepatitis B CHB patients with orwithout cirrhosis treated with entecavir ETV or tenofovir TDF," AASLD 2013, 2013

Papatheodoridis, ONUR Et Al. "Risk and risk factors of hepatocellular carcinoma HCC in Caucasian chronic hepatitis B CHB patients with orwithout cirrhosis treated with entecavir ETV or tenofovir TDF." AASLD 2013 , 2013

Papatheodoridis, G. V. Et Al. (2013) . "Risk and risk factors of hepatocellular carcinoma HCC in Caucasian chronic hepatitis B CHB patients with orwithout cirrhosis treated with entecavir ETV or tenofovir TDF." AASLD 2013 .

@conferencepaper{conferencepaper, author={ONUR KESKİN Et Al. }, title={Risk and risk factors of hepatocellular carcinoma HCC in Caucasian chronic hepatitis B CHB patients with orwithout cirrhosis treated with entecavir ETV or tenofovir TDF}, congress name={AASLD 2013}, city={}, country={}, year={2013}}